Medicinos diapazonas - Company finances
|
EUR
|
2021
From: 2021-10-12
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|
|
Financial data
|
|||||
| Sales revenue | - | 937 | 67,635 | 307,994 | 716,251 |
| Profit before tax | 0 | -3,059 | -31,248 | 156,972 | 512,417 |
| Net profit | 0 | -3,059 | -31,248 | 136,885 | 430,301 |
| Equity | 2,500 | -559 | -31,807 | 105,078 | 535,379 |
| Liabilities | 0 | 2,387 | 41,995 | 94,937 | 185,106 |
| Non-current assets | 0 | 393 | 291 | 661 | 414 |
| Current assets | 2,500 | 1,435 | 9,897 | 194,561 | 719,187 |
| Total assets | 2,500 | 1,828 | 10,188 | 195,222 | 719,601 |
|
Taxes paid
|
|||||
| STI taxes | - | - | 15,903 | 55,076 | 64,532 |
| Social insurance contributions | - | - | 18,099 | 13,200 | 20,572 |
|
Financial indicators
|
|||||
| Revenue change y/y | - | - | +7118.2% | +355.4% | +132.6% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 0.0% | -167.3% | -306.7% | 70.1% | 59.8% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 0.0% | - | - | 130.3% | 80.4% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | - | -326.5% | -46.2% | 44.4% | 60.1% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | -326.5% | -46.2% | 51.0% | 71.5% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | - | 0.9 | 0.3 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | 134 | 1,190 | 7,880 | 19,850 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Medicinos diapazonas - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-02-18 | 2026-02-23 | 2.04 |
| 2026-01-16 | 2026-01-20 | 1.74 |
| 2025-12-16 | 2025-12-18 | 4.03 |
| 2024-02-19 | 2024-02-19 | 0.02 |
| 2024-01-23 | 2024-02-08 | 0.02 |
| 2023-11-16 | 2023-12-07 | 1.26 |
| 2023-10-17 | 2023-11-06 | 1.25 |
| 2023-09-18 | 2023-10-08 | 1.25 |
| 2022-03-16 | 2022-04-06 | 3.73 |
Medicinos diapazonas - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2024-12-08 | 2024-12-28 | 13.45 |
| 2024-12-03 | 2024-12-07 | 14.07 |
| 2024-12-01 | 2024-12-02 | 9.67 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Medicinos diapazonas, UAB (code 305914771) is a Private Limited Liability Company engaged in medical specialists activities. In 2025, the company recorded revenue of EUR 716.3K and net profit of EUR 430.3K, corresponding to a profit margin of 60.1%. Revenue increased by 132.6% year on year in 2025 and by 959.0% over two years, showing a very strong upward trajectory. The profit trend also improved significantly, from a net loss of EUR 31.2K in 2023 to net profit of EUR 136.9K in 2024 and EUR 430.3K in 2025. At the end of 2025, total assets stood at EUR 719.6K, equity at EUR 535.4K, and liabilities at EUR 185.1K. The balance sheet remains strongly equity-funded, with an equity ratio of 74.4% and debt-to-equity of 0.35. Asset turnover was 1.00x, indicating revenue was broadly in line with the asset base. Revenue per employee was EUR 19.9K and profit per employee was EUR 12.0K, reflecting the company’s latest 2025 productivity profile.